| 000 | 007600000a22002170004500 | ||
|---|---|---|---|
| 008 | 110823t xxu||||| |||| 00| 0 eng d | ||
| 020 | _a064282262X | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 110 | _aAustralian Government. National Drug Strategy | ||
| 245 | _aClinical guidelines and procedures for the use of naltrexone in the management of opioid dependence [PDF] | ||
| 260 |
_aCanberra _bCommonwealth of Australia _c2003 |
||
| 300 | _aVI, 50 p. | ||
| 650 | _aAustralië | ||
| 650 | _adrugs | ||
| 650 | _aheroïne | ||
| 650 | _ahulpverlening | ||
| 650 | _analtrexon | ||
| 650 | _abehandelrichtlijnen | ||
| 856 | _uhttp://www.google.com/search?q=Clinical-guidelines-and-procedures-for-the-use-of-naltrexone-in-the-management-of-opioid-dependence | ||
| 999 |
_c11020 _d11020 |
||